The cheap supplement that scientists believe could help fight cancer
Scientists are investigating how the affordable muscle-building supplement creatine may help fight cancer and enhance immunotherapy.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Researchers are exploring the potential for creatine, a popular and inexpensive workout supplement, to aid in the fight against cancer. The substance is being studied for its ability to provide a boost to cancer immunotherapy.
Coverage from ScienceDaily, SciTechDaily, The Independent, and AOL.com emphasizes that the supplement's utility extends beyond muscle growth. Conexiant further notes the intersection of these scientific findings with common fitness discourse.
Future developments will depend on further scientific validation of creatine's role in supporting immunotherapy and cancer treatment.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
What supplement is being linked to cancer fighting?
Creatine, a popular and inexpensive workout supplement.
How might this supplement help in cancer treatment?
According to SciTechDaily, it may provide a significant boost to cancer immunotherapy.
Is creatine only used for muscle building?
While commonly used to build muscle, scientists believe it may also help fight cancer.
Coverage (5)
- Creatine doesn't just build muscle. It may also help fight cancer ScienceDaily · 4h ago
- The cheap supplement that scientists now believe helps fight cancer The Independent · 4h ago
- Side Effects: Bro Science, Actually Conexiant · 4h ago
- This Popular Workout Supplement May Give Cancer Immunotherapy a Big Boost SciTechDaily · 4h ago
- The cheap supplement that scientists believe could help fight cancer AOL.com · 4h ago broke it first
People, places & organizations
Topics
Related trends
Largest study yet reveals which cancers have their own microbiomes
A landmark study is uncovering the specific microbiomes associated with different types of cancer and their impact on immunotherapy.
Alzheimer's: BCG vaccine may reshape brain immune response
New research indicates the tuberculosis vaccine BCG may reduce Alzheimer's risk by reprogramming the brain's immune environment.
Common gym supplement could help fight depression, new research suggests
New research suggests that creatine, a supplement commonly used in gyms, may have potential applications in fighting depression.
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis is expanding its cancer-drug pipeline through the acquisition of U.K.-based biotech firm Myricx Bio in a deal valued up to $1.5 billion.
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.